Theravectys SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Theravectys SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11204
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theravectys SA (TheraVectys) is a clinical development biotech company that develops new generation therapeutic vaccines and immunotherapies. The company develops viral vectors vaccines to support body and prepare against future infections by pre-exposing immune system to partial, dead, inactivated or milder, and attenuated pathogens. It provides lentiviral vectors and t-cell, which includes CAR-T and gene therapy vaccines for many indications. TheraVectys vaccine for human and veterinary indications in oncology and infectious diseases such as HIV, HBV, Malaria, zika, Rift valley fever virus, melanoma, colon cancer, prostate cancer and various solid cancer. It partners with other biotech companies to develop its lentiviral vector platform. Theravectys is headquartered in Paris, France.

Theravectys SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theravectys SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Theravectys SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theravectys SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Theravectys Raises USD5.9 Million in Venture Financing 10
Theravectys Raises US$20 Million In Venture Financing 11
Theravectys Raises USD1.5 Million in Venture Financing 12
Theravectys Raises US$10.5 Million In Third Financing Round 13
Licensing Agreements 14
Immune Design Enters into Licensing Agreement with Theravectys 14
Theravectys Enters into Licensing Agreement with Institut Curie 15
Theravectys SA – Key Competitors 16
Theravectys SA – Key Employees 17
Theravectys SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
May 02, 2017: Theravectys Appoints-New-Executive-Team 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Theravectys SA, Pharmaceuticals & Healthcare, Key Facts 2
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theravectys SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theravectys SA, Deals By Therapy Area, 2012 to YTD 2018 8
Theravectys SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theravectys Raises USD5.9 Million in Venture Financing 10
Theravectys Raises US$20 Million In Venture Financing 11
Theravectys Raises USD1.5 Million in Venture Financing 12
Theravectys Raises US$10.5 Million In Third Financing Round 13
Immune Design Enters into Licensing Agreement with Theravectys 14
Theravectys Enters into Licensing Agreement with Institut Curie 15
Theravectys SA, Key Competitors 16
Theravectys SA, Key Employees 17
Theravectys SA, Other Locations 18

List of Figures
Theravectys SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theravectys SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theravectys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Theravectys SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vale Canada Ltd:企業の戦略・SWOT・財務情報
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Cheesecake Factory Incorporated:戦略・SWOT・企業財務分析
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • AltaGas Ltd (ALA):電力:M&Aディール及び事業提携情報
    Summary AltaGas Ltd (AltaGas) is an energy utility. The company undertakes activities related to extraction, transmission, distribution and storage of natural gas. AltaGas generates electricity utilizing diverse fuel sources, including wind, run-of-river hydro, geothermal and gas-fired generation pl …
  • J.E. Dunn Construction Group, Inc.:企業の戦略的SWOT分析
    J.E. Dunn Construction Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Recursion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recursion Pharmaceuticals Inc (Recursion Pharmaceuticals) is a biotechnology company that develops novel therapies for the treatment of rare genetic diseases. The company’s pipeline products include novel drugs for various diseases such as ataxia-telangiectasia, cerebral cavernous malformati …
  • Benvenue Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Benvenue Medical, Inc (Benvenue Medical) is a manufacturer, designer and distributor of minimally invasive systems and other medical devices. The product portfolio of the company includes Luna, a 3D interbody fusion system designed for the treatment to restore disc height. Blazer, is a verte …
  • Parkland Fuel Corp (PKI):企業の財務・戦略的SWOT分析
    Parkland Fuel Corp (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hertz Global Holdings Inc:企業のM&A・事業提携・投資動向
    Hertz Global Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hertz Global Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Ecobank Transnational Inc:企業の戦略・SWOT・財務情報
    Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report Summary Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cogeco Inc:企業の戦略・SWOT・財務情報
    Cogeco Inc - Strategy, SWOT and Corporate Finance Report Summary Cogeco Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cielo Wind Power LP:企業の戦略的SWOT分析
    Cielo Wind Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Accelovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accelovance Inc (Accelovance) is a contract research organization that offers CRO services, patient recruitment, and clinical call center services in various therapeutic areas including oncology, immunization/infectious disease, CNS, renal care and others. The organization's CRO services inc …
  • Sembcorp Industries Ltd (U96):石油・ガス:M&Aディール及び事業提携情報
    Summary Sembcorp Industries Ltd (Sembcorp) is a diversified energy, water and marine company. It provides solutions across the energy and utilities value chain, with a focus on gas and power, renewables and environment, and merchant and retail sectors. The company carries out production and supply o …
  • Telekom Austria AG (TKA):企業の財務・戦略的SWOT分析
    Telekom Austria AG (TKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Azimut Exploration Inc (AZM):企業の財務・戦略的SWOT分析
    Summary Azimut Exploration Inc (AEI) is a mining company that offers exploration and development of mineral resources. The company carries out the business of acquisition, exploration, and development of gold, copper, silver, chromium, uranium and rare earth element properties. It also offers projec …
  • Columbia University-医療機器分野:企業M&A・提携分析
    Summary Columbia University (CU) is an educational service provider that offers educational and research programs. The university provides educational services and courses through its schools, departments, faculties, centers and institutes. It provides undergraduate and graduate courses in various d …
  • Microbion Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Microbion Corp (Microbion) is a clinical stage biopharmaceutical company that develops therapeutic products. The company develops products for the treatment of chronic infections and antibiotic-resistant infections. It develops environmentally responsible solutions to prevent microbial biofi …
  • Peabody Energy Corp:企業の戦略・SWOT・財務情報
    Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WPP Plc (WPP):企業の財務・戦略的SWOT分析
    WPP Plc (WPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Chime Communications Limited:企業のM&A・事業提携・投資動向
    Chime Communications Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chime Communications Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆